SciBase receives additional order from Castle Biosciences, advancing the collaboration

SciBase Holding announced an additional order to accelerate its ongoing clinical study involving its AI-based dermatology detection and prevention devices. The release indicates incremental commercial and clinical-study momentum, but provides no order value, study details, or financial impact in the available text.